![Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant - Yap - 2019 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant - Yap - 2019 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a833fbe4-fab6-4715-a6d4-899a8c3b1722/bcpt13169-fig-0004-m.jpg)
Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant - Yap - 2019 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Differential Protective Effects of Exenatide, an Agonist of GLP-1 Receptor and Piragliatin, a Glucokinase Activator in Beta Cell Response to Streptozotocin-Induced and Endoplasmic Reticulum Stresses
![Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes - ScienceDirect Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167011503002696-gr2.gif)
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes - ScienceDirect
![Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/285c45c6-d4bc-44a5-a34f-3f377b1ab51c/gr1.jpg)
Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics
![A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/1b4da37e-d140-4113-8b4d-6c73880f4336/hep41147-toc-0001-m.png)
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
![Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram](https://www.researchgate.net/publication/41422599/figure/fig1/AS:340552282329093@1458205399850/Structures-of-native-GLP-1-exenatide-and-liraglutide-The-N-terminal-dipeptide-HA.png)
Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram
Schematic description of the PLGA microsphere preparation process and... | Download Scientific Diagram
![Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing](https://w7.pngwing.com/pngs/475/613/png-transparent-dipeptidyl-peptidase-4-inhibitor-glucagon-like-peptide-1-receptor-agonist-liraglutide-dulaglutide-others-angle-text-pharmaceutical-drug.png)
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
![Spinal microglial β‐endorphin signaling mediates IL‐10 and exenatide‐induced inhibition of synaptic plasticity in neuropathic pain - Ma - 2021 - CNS Neuroscience & Therapeutics - Wiley Online Library Spinal microglial β‐endorphin signaling mediates IL‐10 and exenatide‐induced inhibition of synaptic plasticity in neuropathic pain - Ma - 2021 - CNS Neuroscience & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0acf3641-df12-4f5e-870c-38017d2d7e01/cns13694-fig-0006-m.jpg)
Spinal microglial β‐endorphin signaling mediates IL‐10 and exenatide‐induced inhibition of synaptic plasticity in neuropathic pain - Ma - 2021 - CNS Neuroscience & Therapeutics - Wiley Online Library
![Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium - Journal of the Neurological Sciences Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c79eb132-4651-4a30-9f7b-6589250b6d3a/gr1_lrg.jpg)
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium - Journal of the Neurological Sciences
![A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/3058b433-f18e-43c8-9d5a-12ccc309c921/hep41147-fig-0001-m.jpg)
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
![Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology](https://www.frontiersin.org/files/MyHome%20Article%20Library/543516/543516_Thumb_400.jpg)
Frontiers | GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms | Pharmacology
![Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity | Bentham Science Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cdth/12/1/006.jpg)
Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity | Bentham Science
![Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | SpringerLink Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13300-019-0669-4/MediaObjects/13300_2019_669_Fig3_HTML.png)
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | SpringerLink
![Mechanism of the beneficial and protective effects of exenatide in diabetic rats in: Journal of Endocrinology Volume 220 Issue 3 (2014) Mechanism of the beneficial and protective effects of exenatide in diabetic rats in: Journal of Endocrinology Volume 220 Issue 3 (2014)](https://joe.bioscientifica.com/view/journals/joe/220/3/images/large/291fig3.jpeg)
Mechanism of the beneficial and protective effects of exenatide in diabetic rats in: Journal of Endocrinology Volume 220 Issue 3 (2014)
![A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram](https://www.researchgate.net/profile/Seongah-Han/publication/228103607/figure/fig5/AS:667709293490187@1536205709468/A-schematic-representation-of-the-mechanisms-of-increased-macrophage-apoptosis-in.png)
A schematic representation of the mechanisms of increased macrophage... | Download Scientific Diagram
![Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram](https://www.researchgate.net/profile/Iqbal-Malik/publication/23304097/figure/fig2/AS:310188415438849@1450966089391/Mechanism-of-action-of-sitagliptin-vildagliptin-and-exenatide-GLP-1-is-released-from-L.png)
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
![Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation](https://www.ahajournals.org/cms/asset/1a60304b-27d1-4941-8773-fc3461793191/849fig03.jpeg)
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors | Circulation
![GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet](https://wounds-uk.com/uploads/files/images/dotn/issue/JDN/25-1/7_Morris_Table1.png)